In a large-scale, international study, 12.5 to 20% of patients who were given the drug on a daily basis experienced so-called sustained remission — a state that is almost like being cured. [ + ]

Two separate sets of European researchers have developed their own artificial intelligence methods to identify rare diseases, for which obtaining a definitive diagnosis can be difficult and time-consuming. [ + ]

Vaccitech has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100) to the first participants in a Flu 010 study. [ + ]

Monitoring blood levels with the prick of a finger could be replaced with just a breath, thanks to a ketone-monitoring device developed at the University of Sydney. [ + ]

Scientists have discovered a new internal regulator that helps control the body's response to fight infection — a regulator which could serve as a target for new drugs to tackle autoimmune diseases. [ + ]

SCHOTT, an international technology group in the areas of specialty glass and glass ceramics, has entered into a purchase agreement to acquire Australian microfluidic company MINIFAB. [ + ]

The Queen's Birthday honours have been issued once again, and in 2019 there was no shortage of representatives from the Australian STEM sector on the list. [ + ]

By refining a therapeutic avenue that was previously abandoned because of its severe side effects, researchers came up with a targeted approach that is both effective and safe. [ + ]

Researchers have hypothesised that highly regenerative cells called endometrial epithelial progenitor cells could lead to the abnormal cell growth in endometriosis. [ + ]

Medical technologists Australia wide, as well as scientists and researchers based in Victoria, are encouraged to nominate for several upcoming award opportunities. [ + ]

Using specialised colour imaging, cameras will measure amyloid beta in the retina many years before symptoms of Alzheimer's disease appear. [ + ]

MGC Pharmaceuticals has been granted a cannabis research licence in tandem with RMIT University, while Medlab Clinical has executed a heads of agreement for the further global distribution of its CBD/THC blend. [ + ]

Researchers synthesised a family of molecules that are able to specifically bind a protein found in the cell membrane of more than 90% of neuroblastoma cells. [ + ]

A computer-assisted diagnostic procedure helps physicians detect the growth of low-grade brain tumours earlier and at smaller volumes than visual comparison alone. [ + ]

The 2019 ACTA Trial of the Year Awards recognised the contribution of investigator-led trials to the wellbeing of Australians and improvement to the health system. [ + ]